Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026

Ardelyx (Nasdaq: ARDX) announced it will participate in a fireside chat at the Jefferies Global Healthcare Conference 2026 on June 3 at 9:55 a.m. ET in New York.

Rhea-AI Summary

Ardelyx (Nasdaq: ARDX) announced it will participate in a fireside chat at the Jefferies Global Healthcare Conference 2026 on June 3 at 9:55 a.m. ET in New York.

Investors can access a live webcast and replay via the Ardelyx investor relations website.

Argus May 19 session

-0.33% close to close Open Argus

Details

News Market Reaction – ARDX

On May 19, the day this news came out, ARDX closed 0.33% below the previous close.

Data tracked by StockTitan Argus for the May 19 session.

Market Context

This announcement highlights Ardelyx’s participation in a fireside chat at the Jefferies Global Heal...

Analysis

This announcement highlights Ardelyx’s participation in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, which primarily serves to increase investor and clinician visibility. In context with recent earnings, clinical presentations, and leadership changes, the event continues a pattern of active external engagement. Investors may watch for any new high-level commentary on commercial execution or pipeline priorities shared during the webcast, even though this disclosure itself does not change reported fundamentals.

Key Figures

Conference date: June 3, 2026 Presentation time: 9:55 a.m. ET

Conference date

June 3, 2026

Jefferies Global Healthcare Conference 2026 fireside chat

Presentation time

9:55 a.m. ET

Scheduled time for Jefferies conference fireside chat

Historical Context

5 past events · Latest: May 07

5 events

1. May 07

   Clinical data update

   24h Move

   -1.7%

   Post hoc analysis showed long-term XPHOZAH safety with no meaningful electrolyte issues.

2. Apr 30

   Earnings and update

   24h Move

   +8.7%

   Q1 2026 revenue growth, strong IBSRELA sales, reaffirmed 2026 product guidance and pipeline progress.

3. Apr 27

   Conference poster

   24h Move

   +0.7%

   NKF poster acceptance on long-term XPHOZAH data and sponsored peer exchange on therapy use.

4. Apr 23

   Conference abstract

   24h Move

   -1.0%

   DDW 2026 poster and product theater focused on IBS-C treatment patterns and education.

5. Apr 20

   Leadership change

   24h Move

   -2.3%

   Appointment of new Chief Legal Officer succeeding long‑tenured predecessor across legal and compliance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced its participation in a fireside chat at the Jefferies Global Healthcare Conference 2026 on June 3 at 9:55 a.m. ET in New York.

To access the live webcast of the fireside chat, please visit the Events and Presentations page within the Ardelyx website at ir.ardelyx.com. A replay of the webcast will be available following the event.

About Ardelyx, Inc.
Ardelyx is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). The company’s pipeline includes the Phase 3 development of IBSRELA for chronic idiopathic constipation (CIC) and RDX10531, a next-generation NHE3 inhibitor with potential application across multiple therapeutic areas. Ardelyx works with partners to develop and commercialize our products outside of the United States. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

Investor & Media Contact:
Lisa Caperelli
lcaperelli@ardelyx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Ardelyx (ARDX) present at the Jefferies Global Healthcare Conference 2026?

Ardelyx will participate in a fireside chat on June 3, 2026, at 9:55 a.m. ET in New York. According to Ardelyx, this session is part of the Jefferies Global Healthcare Conference 2026 agenda.

How can investors access the Ardelyx (ARDX) Jefferies 2026 conference webcast?

Investors can access the live webcast of Ardelyx’s fireside chat by visiting the Events and Presentations page on the Ardelyx investor relations website at ir.ardelyx.com. According to Ardelyx, a replay will also be available after the event.

Will a replay be available for Ardelyx’s Jefferies Global Healthcare Conference 2026 presentation?

Yes, a replay of Ardelyx’s fireside chat webcast will be available after the event. According to Ardelyx, investors can access the replay on the Events and Presentations section of its investor relations website, providing flexible viewing for those unable to watch live.

What type of session will Ardelyx (ARDX) hold at Jefferies Global Healthcare Conference 2026?

Ardelyx will participate in a fireside chat session at the Jefferies Global Healthcare Conference 2026. According to Ardelyx, this discussion will take place on June 3 at 9:55 a.m. ET in New York and will be available via webcast.

Where is Ardelyx’s Jefferies Global Healthcare Conference 2026 appearance being held?

Ardelyx’s fireside chat will be held in New York as part of the Jefferies Global Healthcare Conference 2026. According to Ardelyx, the session occurs on June 3 at 9:55 a.m. ET and will be streamed online for investors.